EDB Webinar on Singapore’s Biopharmaceutical Landscape
On 15 October 2021, the Singapore Economic Development Board (EDB) held a webinar titled “Discover the true landscape of Singapore’s biopharmaceutical industry”. The webinar explored Singapore’s efforts to position itself as a leading global biopharmaceutical hub and discussed future trends and prospects in the industry. The webinar also highlighted how public-private partnerships and the ability to attract talent were instrumental in fostering productivity and innovation within the industry.
CPR CEO Hideaki Shimada was one of the invited guest speakers who shared his perspectives on how CPR has grown and benefitted from Singapore’s R&D ecosystem. During his presentation, Dr Shimada focused on how CPR has drawn on Singapore’s strong infrastructure for biomedical research and supportive policies to establish collaborations with Singapore’s science community, nurture innovation and strengthen its drug discovery platforms.
